FIELD: medicine.
SUBSTANCE: invention refers to medicine. A method of treating a patient suffering a metabolic disorder involves the stage of introducing into a patient suffering metabolic syndrome a pharmaceutical composition containing (1) at least one compound which stimulates higher activity of central dopaminergic neurons in said subject, and (2) at least one compound which stimulates lower activity of central noradrenergic neurons in said subject wherein the relation of said at least one compound which stimulates higher activity of central dopaminergic neurons to said at least one compound which stimulates lower activity of central noradrenergic neurons in said pharmaceutical composition makes approximately 500:1 to 1:500 at weight to weight basis (wt:wt).
EFFECT: higher clinical effectiveness.
24 cl, 14 ex
